Allegria Therapeutics Overview

  • Year Founded
  • 2023

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $3.5M

  • Investors
  • 1

Allegria Therapeutics General Information

Description

Provider of biotech research services intended to improve the treatment landscape of therapeutics. The company offers research and development focused on mast cells as mediators of allergy and inflammatory diseases, a class of indications that constitutes an increasing burden worldwide, enabling customers to lead a healthy lifestyle.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Walder Wyss AG
  • Aeschenvorstadt 48
  • 4051 Basel
  • Switzerland
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • Walder Wyss AG
  • Aeschenvorstadt 48
  • 4051 Basel
  • Switzerland

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Allegria Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Seed Round 06-May-2024 $3.5M Completed Startup
To view Allegria Therapeutics’s complete valuation and funding history, request access »

Allegria Therapeutics Executive Team (1)

Name Title Board Seat
Maria Dongen Ph.D Co-Founder, Chief Executive Officer & Board Member
To view Allegria Therapeutics’s complete executive team members history, request access »

Allegria Therapeutics Board Members (3)

Name Representing Role Since
Maria Dongen Ph.D Allegria Therapeutics Co-Founder, Chief Executive Officer & Board Member
Sara Garcia Ph.D Self Board Member
Sascha Oliver Bucher Forty51 Ventures Board Member
To view Allegria Therapeutics’s complete board members history, request access »

Allegria Therapeutics Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Forty51 Ventures Venture Capital Minority
To view Allegria Therapeutics’s complete investors history, request access »

Allegria Therapeutics FAQs

  • When was Allegria Therapeutics founded?

    Allegria Therapeutics was founded in 2023.

  • Who is the founder of Allegria Therapeutics?

    Maria Dongen Ph.D is the founder of Allegria Therapeutics.

  • Who is the CEO of Allegria Therapeutics?

    Maria Dongen Ph.D is the CEO of Allegria Therapeutics.

  • Where is Allegria Therapeutics headquartered?

    Allegria Therapeutics is headquartered in Basel, Switzerland.

  • What industry is Allegria Therapeutics in?

    Allegria Therapeutics’s primary industry is Drug Discovery.

  • Is Allegria Therapeutics a private or public company?

    Allegria Therapeutics is a Private company.

  • What is Allegria Therapeutics’s current revenue?

    The current revenue for Allegria Therapeutics is .

  • How much funding has Allegria Therapeutics raised over time?

    Allegria Therapeutics has raised $3.5M.

  • Who are Allegria Therapeutics’s investors?

    Forty51 Ventures has invested in Allegria Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »